Study finds that #InterferonAlpha benefits patients with #MyeloproliferativeNeoplasms by driving mutant #BloodStemCells to become shorter-lived #WhiteBloodCells, suggesting that more targeted treatments could reduce its significant #SideEffects.
#BloodCancer #BloodCancerTreatment